In a report released today, William Bonello from Craig-Hallum reiterated a Buy rating on Guardant Health (GH – Research Report), with a price ...
BTIG analyst Mark Massaro reiterated a Buy rating on Guardant Health (GH – Research Report) yesterday and set a price target of $60.00. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback